Table 2.
Drug | Formulation | Dosage (mg) | Maximum 24 h dose (mg) | Time of peak levels | Elimination half life (H) | Bioavailability (%) |
---|---|---|---|---|---|---|
Sumatriptan | SI | 6 | 6 | 12 min | 2 | 97 |
OT | 50–100 | 200 | 2–3 h | 2 | 15 | |
NS | 20 | 40 | 1 h | 2 | 17 | |
Rizatriptan | ODT | 10 | 30 | 1–2 h | 2 | 14 |
Zolmitriptan | ODT | 2.5 | 10 | 3 h | 2.5–3 | 40–50 |
Almotriptan | OT | 12.5 | 12.5 | 1.5–2 h | 3.5 | 70 |
Eletriptan | OT | 40 | 80 | 1.5–2 h | 4 | 50 |
Naratriptan | OT | 2.5 | 5 | 2–3 h | 6 | 60–70 |
frovatriptan | OT | 2.5 | 7.5 | 2–4 h | 26 | 20–40 |
SI subcutaneous injection, OT oral tablet, NS nasal spray, ODT oral dispersible tablet, min minutes, h hour